Engineers Gate Manager’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Engineers Gate Manager’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Sell	3,680 -2,721	-43%	-$141K	﹤0.01%	1895
2026 Q1	$308K	Sell	6,401 -33,472	-84%	-$1.48M	﹤0.01%	1696
2025 Q4	$1.64M	Sell	39,873 -47,591	-54%	-$1.91M	0.02%	796
2025 Q3	$3.4M	Buy	87,464 +28,189	+48%	+$916K	0.04%	527
2025 Q2	$1.64M	Buy	+59,275	New	+$1.51M	0.02%	843
2024 Q4	–	Sell	-11,871	Closed	-$297K	–	2419
2024 Q3	$297K	Sell	11,871 -698	-6%	-$17K	0.01%	1626
2024 Q2	$235K	Sell	12,569 -2,365	-16%	-$44.3K	0.01%	1580
2024 Q1	$295K	Buy	+14,934	New	+$292K	0.01%	1470
2023 Q4	–	Sell	-10,326	Closed	-$179K	–	2106
2023 Q3	$179K	Sell	10,326 -9,386	-48%	-$158K	0.01%	1515
2023 Q2	$278K	Buy	19,712 +7,210	+58%	+$96.5K	0.01%	1333
2023 Q1	$135K	Buy	+12,502	New	+$165K	0.01%	1484
2022 Q3	–	Sell	-14,482	Closed	-$140K	–	1858
2022 Q2	$140K	Buy	+14,482	New	+$135K	0.01%	1696
2022 Q1	–	Sell	-24,336	Closed	-$286K	–	2098
2021 Q4	$286K	Buy	+24,336	New	+$299K	0.01%	1434
2021 Q2	–	Sell	-21,360	Closed	-$395K	–	1826
2021 Q1	$395K	Buy	+21,360	New	+$437K	0.02%	1147

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Engineers Gate Manager's KNSA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Kiniksa Pharmaceuticals (KNSA) stake by 43% in Q2 2026, selling an estimated $141K and leaving 3,680 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Engineers Gate Manager first reported a position in KNSA in Q1 2021 and has held it in 14 quarters since. The position peaked at $3.4M in Q3 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Engineers Gate Manager held 3,680 shares of Kiniksa Pharmaceuticals worth $235K as of Q2 2026.
Engineers Gate Manager sold 2,721 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $141K.
Kiniksa Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1895 holding.
Engineers Gate Manager first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
Engineers Gate Manager's Kiniksa Pharmaceuticals position peaked at $3.4M in Q3 2025.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.